What is Lab Central?
LabCentral is a non-profit organization established in 2013, serving as a vital launchpad for high-potential life sciences and biotech start-ups. Headquartered in Massachusetts, United States, the company provides comprehensive support, including first-class facilities, administrative services, a skilled laboratory operations team, and domain-relevant programming. By offering these essential resources, LabCentral empowers early-stage companies to rapidly initiate and scale their laboratory operations, thereby accelerating scientific discovery and commercialization within the biotech ecosystem.
How much funding has Lab Central raised?
Lab Central has raised a total of $22.8M across 2 funding rounds:
Debt
$350K
Other Financing Round
$22.4M
Debt (2020): $350K with participation from PPP
Other Financing Round (2021): $22.4M led by Thermo Fisher Scientific and Waters
Key Investors in Lab Central
Thermo Fisher Scientific
Thermo Fisher Scientific is a global leader in serving science, providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. Their investment likely supports the growth of biotech start-ups that utilize their technologies.
Waters
Waters Corporation is a leader in life science, healthcare, and industrial analytical measurement, known for its chromatography and mass spectrometry solutions. Their participation suggests a strategic interest in companies leveraging advanced analytical technologies for drug discovery and development.
PPP
Public-Private Partnership
What's next for Lab Central?
With substantial enterprise-level funding and a recent strategic investment, LabCentral is poised for continued expansion and enhanced support for its resident companies. The company's focus on providing critical infrastructure and operational support suggests a strategy aimed at solidifying its role as a premier incubator for biotech innovation. Future developments will likely involve scaling its facilities, expanding its network of strategic partners, and further refining its service offerings to meet the evolving needs of the life sciences start-up community. This sustained backing indicates confidence in LabCentral's model for driving growth and success in the competitive biotech landscape.
See full Lab Central company page
